G376-0311 Screening compound: 1,3,7-trimethyl-N-({1-[(4-methylphenyl)methyl]pyrrolidin-3-yl}methyl)-2,4-dioxo-1H,2H,3H,4H-pyrido[2,3-d]pyrimidine-5-carboxamide

G376-0311 Screening compound: 1,3,7-trimethyl-N-({1-[(4-methylphenyl)methyl]pyrrolidin-3-yl}methyl)-2,4-dioxo-1H,2H,3H,4H-pyrido[2,3-d]pyrimidine-5-carboxamide
G376-0311 Screening compound: 1,3,7-trimethyl-N-({1-[(4-methylphenyl)methyl]pyrrolidin-3-yl}methyl)-2,4-dioxo-1H,2H,3H,4H-pyrido[2,3-d]pyrimidine-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G376-0311
1,3,7-trimethyl-N-({1-[(4-methylphenyl)methyl]pyrrolidin-3-yl}methyl)-2,4-dioxo-1H,2H,3H,4H-pyrido[2,3-d]pyrimidine-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G376-0311

Molecular Formula

C24H29N5O3 (C24 H29 N5 O3)

Compound Name

1,3,7-trimethyl-N-({1-[(4-methylphenyl)methyl]pyrrolidin-3-yl}methyl)-2,4-dioxo-1H,2H,3H,4H-pyrido[2,3-d]pyrimidine-5-carboxamide

IUPAC name

137-trimethyl-N-({1-[(4-methylphenyl)methyl]pyrrolidin-3-yl}methyl)-24-dioxo-1H2H3H4H-pyrido[23-d]pyrimidine-5-carboxamide

SMILES

Cc1ccc(CN2CC(CNC(c3cc(C)nc(N(C)C(N4C)=O)c3C4=O)=O)CC2)cc1

InChI

InChI=1S/C24H29N5O3/c1-15-5-7-17(8-6-15)13-29-10-9-18(14-29)12-25-22(30)19-11-16(2)26-21-20(19)23(31)28(4)24(32)27(21)3/h5-8,11,18H,9-10,12-14H2,1-4H3,(H,25,30)/t18-/m1/s1

InChI Key

UJNBXEZGBWPJOM-GOSISDBHSA-N

MDL Number (MFCD)

MFCD27138344

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

435.53

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.829

Distribution Coefficient, logD

-0.901

Water Solubility, LogSw

-3.22

Polar Surface Area

69.492

Acid Dissociation Constant (pKa)

13.11

Base Dissociation Constant (pKb)

11.13

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

41.70

G376-0311 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with G376-0311 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G376-0311?
Check Price and Availability of G376-0311, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G376-0311 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G376-0311
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G376-0311
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G376-0311 available by request